Abstract:tert -Butyl ( S )-6-chloro-5-hydroxy-3-oxohexanoate (( S )-CHOH) is a valuable chiral synthon, which is used for the synthesis of the cholesterol-lowering drugs atorvastatin and rosuvastatin. To date, only the alcohol dehydrogenases from Lactobacillus brevis (LbADH) and Lactobacillus kefir (LkADH) have demonstrated catalytic activity toward the asymmetric reduction of tert -butyl 6-chloro-3,5-dioxohexanoate (CDOH) to ( S )-CHOH. Herein, a tetrad mutant of LkADH (LkTADH), A94T/F147L/L199H/A202L, was screened to be more efficient in this bioreduction process, exhibiting a 3.7- and 42-fold improvement in specific activity toward CDOH (1.27 U/mg) over LbADH (0.34 U/mg) and wild-type LkADH (0.03 U/mg), respectively. The molecular basis for the improved catalytic activity of LkTADH toward CDOH was investigated using homology modeling and docking analysis. Two major issues had a significant impact on the biocatalytic efficiency of this process, including (i) the poor aqueous stability of the substrate and (ii) partial substrate inhibition. A fed-batch strategy was successfully developed to address these issues and maintain a suitably low substrate concentration throughout the entire process. Several other parameters were also optimized, including the pH, temperature, NADP + concentration and cell loading. A final CDOH concentration of 427 mM (100 g/L) gave ( S )-CHOH in 94 % yield and 99.5 % e.e. after a reaction time of 38 h with whole cells expressing LkTADH. The space–time yield and turnover number of NADP + in this process were 10.6 mmol/L/h and 16,060 mol/mol, respectively, which were the highest values ever reported. This new approach therefore represents a promising alternative for the efficient synthesis of ( S )-CHOH.

A New and Facile Preparation of Tert-Butyl (3R,5s)-6-hydroxy-3,5-o-isopropylidene-3,5-dihydroxyhexanoate

Pd-Catalyzed TBHP-Mediated Selective Wacker-Type Oxidation and Oxo-acyloxylation of Olefins Using a 2-(1H-indazol-1-yl)quinoline Ligand

A Highly Stereoselective Synthesis of C-24 and C-25 Oxysterols from Desmosterol.

New Synthesis Process of 2,7-Dimethyl-2,4,6-octatriene-1,8-dial

A New Way to Synthesis of (S)-Tert-butyl 6-Benzyloxy-5-hydroxy-3-oxohexanoate

Enantioselective One‐Pot Reaction: Organocatalyzed Synthesis of Fully Functionalized Oxabicyclo[2.2.2]octanes with Seven Contiguous Stereocenters

Improved Synthesis of Methyl 3-Oxo-2,6,6-trimethylcyclohex-1-ene-1-carboxylate, an A-ring Intermediate for (±)Strigol

An Improved Synthesis of 2,2-Diethoxypropane by Using Triethyl Orthofomate

Investigation on the synthesis of 25-hydroxycholesterol.

Chemoenzymatic Synthesis of ((4R,6s)-6-hydroxymethyl-2,2-dimethyl-1,3-dioxinan-4-yl)-acetic Acid Tert-Butyl Ester

A convenient method for synthesis of novel cyclic ethers (1R, 2R, 3R, 5S, 7S, 9R, 12R)-3-(t-butyldimethylsilyl)oxy-7-methoxymethyloxy-2, 10-dimethyl-12-oxatricyclo [7.2.1.05,12] dodecane

Chemo‐, Regio‐ and Stereoselective Preparation of (Z)‐2‐Butene‐1,4‐Diol Monoesters via Pd‐Catalyzed Decarboxylative Acyloxylation

Study On Synthesis Of Ethyl 3-Oxo-(+/-)-6,7-Di-O-Isopropylidene-6,7-Dihydroxyheptanoate

Acetalization of Carbonyl Compounds with 2,2,4-Trimethyl-1,3-pentanedio Catalyzed by Novel Carbon Based Solid Acid Catalyst

Synthesis of 2,4-Diisopropyl-5,5-dimethyl-1,3-dioxane Catalyzed by Brønsted Acidic Ionic Liquids

Stereoselective Synthetic Approach to β‐Trifluoromethyl Vinyl Ethers and Diethers via Reaction of (E)-1,2-dichloro-3,3,3-trifluoroprop-1-ene with Phenols

The Efficient Preparation of Isomeric (1,3-Dioxanyl/1,3-dioxolanyl)phenols

Highly efficient enzymatic synthesis of tert -butyl ( S )-6-chloro-5-hydroxy-3-oxohexanoate with a mutant alcohol dehydrogenase of Lactobacillus kefir

A Facile New Procedure for the Deprotection of Allyl Ethers under Mild Conditions

Highly Efficient Asymmetric Synthesis of Vinylic Amino Alcohols by Zn-promoted Benzoyloxyallylation of Chiral N-tert-butanesulfinyl Imines: Facile and Rapid Access to (-)-Cytoxazone.

Stereoselective synthesis, structural characterization, and properties of 1,2-O-isopropylidene-3-C-(5-phenyl-1,2,4-oxadiazol-3-yl)-β-d-psicopyranose